TIDMRPSE 
 
RNS Number : 5236Y 
Research Pharmaceutical SRV, Inc 
04 September 2009 
 

September 4, 2009 
 
 
 
 
 
 
ReSearch Pharmaceutical Services, Inc. 
Resignation of Nominated Adviser 
 
 
Further to the announcement issued on August 26, 2009, ReSearch Pharmaceutical 
Services, Inc. (the "Company") announces that following the cancellation of its 
Common Stock from trading on AIM this morning Arbuthnot Securities Limited has 
resigned as Nominated Adviser and Broker to the Company. As a result the Company 
expects trading in its Warrants on AIM to be suspended and if within one month 
from such suspension the Company does not appoint another Nominated Adviser 
(which appointment the Company believes to be unlikely) the admission of the 
Warrants to trading on AIM will also be cancelled on October 5, 2009. 
 
 
For further information please contact: 
 
 
ReSearch Pharmaceutical Services, Inc.:                             +1 215 540 
0700 
Daniel M. Perlman, Chairman & Chief Executive Officer 
Steven Bell, Chief Financial Officer 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 APPFGGGLRFGGLZM
Res.Phm.Reg S (LSE:RPSE)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Res.Phm.Reg S Charts.
Res.Phm.Reg S (LSE:RPSE)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Res.Phm.Reg S Charts.